E88.10

Clinical Causes: Genetic mutations leading to congenital lipodystrophy Secondary effects of medications such as antiretroviral therapy used for HIV Autoimmune diseases that target fat tissue Trauma or injury to fat tissue Infections that affect fat cells Malnutrition or severe weight loss Metabolic disorders that interfere with fat tissue normal function Certain cancers involving fat tissue

Key Symptoms: Noticeable loss of fat in areas like the face, arms, legs, or buttocks Unusual fat accumulation in certain parts of the body, such as the abdomen or neck Changes in body shape and appearance Muscle weakness or fatigue Increased hunger or abnormal appetite Elevated blood sugar levels, potentially leading to diabetes High blood triglycerides and cholesterol Signs of insulin resistance, such as skin darkening or acanthosis nigricans Possible development of liver problems from fat accumulation

Diagnosis Path: Doctors usually diagnose lipodystrophy based on medical history and physical examinations focusing on fat distribution. Additional tests may include blood tests to evaluate glucose and lipid levels, and imaging studies like MRI or ultrasound to assess fat tissue. In some cases, a biopsy of fat tissue might be performed to understand tissue changes better. Since the condition can vary widely, a thorough assessment helps determine whether the lipodystrophy is generalized or localized and whether it is acquired or inherited.

Treatment Protocols: Lifestyle modifications such as balanced diet and regular exercise Medications to control blood sugar levels, like insulin or oral antidiabetics Lipid-lowering agents to manage cholesterol and triglycerides Hormonal therapies in some cases Reconstructive surgeries or cosmetic procedures for improving appearance Addressing underlying causes if identified, such as adjusting medications Monitoring for metabolic and cardiovascular complications Supportive therapies including counseling or support groups for affected individuals